In 2023, Resmed completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Resmed has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Resmed’s data sources below and access millions more through our Disclosure Search.
In 2023, the total operational greenhouse gas (GHG) emissions of Resmed amounted to 28,392 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Resmed increased by 13.3%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
In 2023, the total Scope 1 emissions of Resmed were 4,453 metric tons of CO₂ equivalent (tCO₂e). a
Since 2021, Resmed's Scope 1 emissions have increased by 84.16%, reflecting a rising long-term trend in Scope 1 emissions over time. a
Compared to the previous year (2022), Resmed's Scope 1 emissions increased by 18.97%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
In 2023, Resmed reported Scope 2 greenhouse gas (GHG) emissions of 23,939 tCO₂e without specifying the calculation method. a
Since 2021, Resmed's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have remained relatively stable, indicating that Resmed 's emissions have plateaued with no significant change in its energy consumption footprint. a
Compared to the previous year (2022), Resmed's Scope 2 emissions (Unspecified Calculation Method) rose by 12.3% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
In 2023, Resmed reported its Scope 2 emissions using an unspecified methodology. a
In 2023, Resmed reported Scope 1 greenhouse gas (GHG) emissions of 4,453 tCO₂e and total revenues of USD 4,223 millions. This translates into an emissions intensity of 1.05 tCO₂e per millions USD. a
In 2023, Resmed reported a Scope 1 emissions intensity of 1.05 tCO₂e per millions USD. Compared to the peer group median of 3.75 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
In 2023, Resmed ranked 3 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Resmed among the top performers, with one of the lowest emissions intensities relative to peers. a